BMTI Financial Facts
Basic and diluted net loss per share: -0.16Research and development: 1.93M
See Full Income Statement
Accrued payroll, employee benefits and payroll taxes: 2.03M
Cash and cash equivalents: 15.49M
See Full Balance Sheet
Earnings History for BioMimetic Therapeutics Inc. (BMTI)
|
Expand Research on BMTI
| Next EPS Date | 3/13/13 *Est. | EPS Growth Rate | +36.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +8.8% | Revenue Growth Rate | -99.8% *Last Qtr. |
| Average % Move 1-Wk after EPS | -11.5% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/5/12 | Q312 | -$0.16 | -$0.23 | +$0.07 | $688.7K | $390K | N/A / N/A | N/A | +149.1% | Details | |
| 5/9/12 | Q112 | -$0.22 | N/A | N/A | $466.38M | $398.7M | N/A / N/A | N/A | +279.6% | Details | |
| 3/13/12 | Q411 | -$0.35 | -$0.26 | -$0.09 | $458K | $310K | N/A / N/A | N/A | +341.4% | Details | |
11/8/11  |
 |
Q311 | -$0.25 | -$0.31 | +$0.06 | $428M | $350K | N/A / N/A | N/A | +195.6% | Details |
| 5/9/11 |
Q111 | -$0.28 | -$0.35 | +$0.07 | $390K | $210K | N/A / N/A | N/A | -29.3% | Details | |
| 3/10/11 |
|
Q410 | -$0.36 | -$0.34 | -$0.02 | $400K | $380K | N/A / N/A | N/A | -25.9% | Details |
